Category: CareFusion Corp.
Cook Medical rearranges its management, naming Rob Lyles as its new executive vice president.
Cook Medical named Rob Lyles executive vice president, the latest move in a larger management shift at the Indiana medtech maker.
Lyles was formerly vice president of Cook's peripheral intervention division. He has been with the company since 2003 and was named division VP in 2007. Lyles' promotion follows the advancement of Pete Yonkman to president of the Cook Medical. Mark Breedlove, a 19-year veteran of Cook Medical, will succeed Lyles as VP of the peripheral intervention division.
CareFusion agrees to pony up $500 million for GE Healthcare's Vital Signs medical consumables business.
CareFusion, Tyco Healthcare and Cardinal Health land a collective $1 billion in supply contracts with the U.S. Dept. of Defense.
The United States Department of Defense awarded nearly $1.1 billion worth of contracts to 3 medical device firms.
CareFusion's stock ticks down after despite the medical device company's report of better-than-expected fiscal 1st-quarter earnings.
CareFusion (NYSE:CFN) shares slipped today after the medical device company reported its fiscal 1st-quarter results, despite stronger-than-forecast earnings per share.
The FDA updates the recall of CareFusion's AVEA ventilator to include its use on infants above 5,000 feet of altitude.
The FDA updated the Class I recall of CareFusion's (NYSE:CFN) AVEA ventilators, to include those used on infants under 5.5 pounds at altitudes above 5000 feet.
California medical device maker CareFusion updates on the latest recall affecting its AVEA ventilators, which were the subject of 5 complaints from neonatal care providers.
CareFusion (NYSE:CFN) issued an update on the recall of its AVEA ventilators after receiving 5 complaints from a clinical providing neonatal care. No injuries have yet been directly attributed to the issues with the ventilators, CareFusion noted.
Following customer reports of keyboard malfunctions on CareFusion's already-troubled Alaris infusion pump line, the FDA issues the highest level recall warning.
The FDA sent out the highest-risk recall notice for the an infusion pump made by CareFusion (NYSE:CFN), the most recent warning to customers involving the company's Alaris product line.